These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10067689)

  • 1. Mild illness at or after measles vaccination does not reduce seroresponse in young children.
    Scott S; Cutts FT; Nyandu B
    Vaccine; 1999 Feb; 17(7-8):837-43. PubMed ID: 10067689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire.
    Cutts FT; Nyandu B; Markowitz LE; Forsey T; Zell ER; Othepa O; Wilkins K
    Vaccine; 1994 Nov; 12(14):1311-6. PubMed ID: 7856296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
    Izadi S; Zahraei SM; Salehi M; Mohammadi M; Tabatabaei SM; Mokhtari-Azad T
    Vaccine; 2018 Jan; 36(5):631-636. PubMed ID: 29289382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine.
    Bolotovski VM; Grabowsky M; Clements CJ; Albrecht P; Brenner ER; Zargaryantzs AI; Litvinov SK; Mikheyeva IV
    Int J Epidemiol; 1994 Oct; 23(5):1069-77. PubMed ID: 7860158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
    Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
    Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
    King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
    JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroresponse to the second measles vaccine dose at school entry in Qassim province, Saudi Arabia.
    Khalil MK; Nadrah HM; Al Yahia OA; ElGhazali G
    East Mediterr Health J; 2011 Mar; 17(3):191-5. PubMed ID: 21735958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.
    Pabst HF; Spady DW; Carson MM; Krezolek MP; Barreto L; Wittes RC
    Vaccine; 1999 Apr; 17(15-16):1910-8. PubMed ID: 10217589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced seroconversion to measles in infants given vitamin A with measles vaccination.
    Semba RD; Munasir Z; Beeler J; Akib A; Muhilal ; Audet S; Sommer A
    Lancet; 1995 May; 345(8961):1330-2. PubMed ID: 7752754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles immunization strategy: measles antibody response following MMR II vaccination of children at one year of age.
    Ratnam S; West R; Gadag V; Burris J
    Can J Public Health; 1996; 87(2):97-100. PubMed ID: 8753636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?
    Michel R; Berger F; Ravelonarivo J; Dussart P; Dia M; Nacher M; Rogier S; Moua D; Sarr FD; Diop OM; Sall AA; Baril L
    Vaccine; 2015 May; 33(20):2301-6. PubMed ID: 25843268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine.
    Stefano I; Sato HK; Pannuti CS; Omoto TM; Mann G; Freire MS; Yamamura AM; Vasconcelos PF; Oselka GW; Weckx LW; Salgado MF; Noale LF; Souza VA
    Vaccine; 1999 Mar; 17(9-10):1042-6. PubMed ID: 10195613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.